A SECOND PHASE III MULTICENTER PLACEBO CONTROLLED STUDY OF 2 DOSAGES OF MODIFIED RELEASE TAMSULOSIN IN PATIENTS WITH SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA
- 1 November 1998
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 160 (5), 1701-1706
- https://doi.org/10.1016/s0022-5347(01)62386-3
Abstract
The Journal of Urology 160 (1998) 1701-1706. doi:10.1016/S0022-5347(01)62386-3Received by publisher: 0000-01-01Harvest Date: 2016-01-04 12:20:25DOI: 10.1016/S0022-5347(01)62386-3Page Range: 1701-170Keywords
This publication has 13 references indexed in Scilit:
- TamsulosinDrugs, 1996
- Tamsulosin and Chlormadinone for the Treatment of Benign Prostatic HyperplasiaScandinavian Journal of Urology and Nephrology, 1996
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaThe New England Journal of Medicine, 1996
- The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasiaUrology, 1996
- The International Terazosin Trial: A Multicentre Study of the Long-Term Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1996
- Tamsulosin, a selective α1c‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- Alpha1-adrenoceptors in human prostate: Characterization and binding characteristics of alpha1-antagonistsLife Sciences, 1994
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic HypertrophyJournal of Urology, 1990
- Pharmacological Receptors in the ProstateBritish Journal of Urology, 1973